The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 14, 1992

Filed:

Aug. 23, 1989
Applicant:
Inventors:

Lawrence T Malek, Brampton, CA;

Cheryl Davey, Toronto, CA;

Graham Henderson, Mississauga, CA;

Roy Sooknanan, Toronto, CA;

Assignee:

Cangene Corporation, Mississauga, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12P / ; C12Q / ; C07H / ; C07H / ;
U.S. Cl.
CPC ...
435 91 ; 435-6 ; 4351723 ; 435810 ; 436 94 ; 436508 ; 536 27 ; 536 28 ;
Abstract

This invention relates to an improved process for amplifying a specific nucleic acid sequence. The process involves synthesizing single-stranded RNA, single-stranded DNA and Double-stranded DNA. The single-stranded RNA is a first template for a first primer, the single-stranded DNA is a second template for a second primer, and the double stranded DNA is a third template for synthesis of a plurality of copies of the first template. A sequence of the first primer or the second primer is complementary to a sequence of the specific nucleic acid and a sequence of the first primer or the second primer is homologous to a sequence of the specific nucleic acid. The improvement of the amplification process involves the addition of DMSO alone or in combination with BSA, which improves the specificity and efficiency of the amplification. The amplification process may be used to increase the quantity of a specific nucleic acid sequence to allow detection, or to increase the purity of a specific nucleic acid sequence as a substitute for conventional cloning methodology.

Published as:
CA2065003A1; WO9102818A1; AU6336590A; EP0487628A1; NZ235009A; US5130238A; JPH04507197A; AU647411B2; KR960005737B1; EP0487628B1; ATE154644T1; DE69030955D1; JP2648802B2; FI100192B; ES2104611T3; DK0487628T3; DE69030955T2; CA2065003C;

Find Patent Forward Citations

Loading…